Product Program year 2025 Source: CMS Open Payments

Annovera

Drug Contraception

NDC 68308-752-01

Open in the dashboard

General payments

$784,674

1,431 payments

Research payments

$0

0 payments

Through program year 2025, $784,674 in general payments and $0 in research payments were reported against Annovera (Contraception).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $784,674 1,431

Breakdown

Who paid General payments · program year 2025
  1. Mayne Pharma Inc. $784,674 1,431 payments
Top recipients General payments · program year 2025
  1. Dale Stovall Obstetrics & Gynecology · Dallas, TX $90,709 12% · 71 payments
  2. Anita Nelson Obstetrics & Gynecology · Torrance, CA $80,677 10% · 52 payments
  3. Lee Shulman Obstetrics & Gynecology · Chicago, IL $74,976 10% · 54 payments
  4. Andrew London Gynecology · Lutherville, MD $68,370 9% · 56 payments
  5. Jay Cohen Obstetrics & Gynecology · Plantation, FL $58,632 7% · 49 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $521,025 67% · 278 practitioners
  2. Gynecology Obstetrics & Gynecology $139,328 18% · 17 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $31,527 4% · 132 practitioners
  4. Physician Assistant $16,737 2% · 55 practitioners
  5. Reproductive Endocrinology Obstetrics & Gynecology $16,503 2% · 2 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $184,075 23% · 161 recipients
  2. Texas $170,544 22% · 104 recipients
  3. California $126,598 16% · 194 recipients
  4. Illinois $76,675 10% · 15 recipients
  5. Maryland $69,097 9% · 9 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,431 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record